Showing results (401-410 of 1,823) with videos related to

Sort By:
Pageof 183
Contemporary Clinical Trials|March 12, 2021
Shotgun: A Bayesian seamless phase I-II design to accelerate the development of targeted therapies and immunotherapyLiyun Jiang, Ruobing Li, Fangrong Yan, et al.
Pharmaceutical Statistics|April 1, 2021
Incorporating historical information to improve phase I clinical trialsYanhong Zhou, J Jack Lee, Shunguang Wang, et al.
The British Journal of Ophthalmology|February 14, 2015
Corneal confocal microscopy for assessment of diabetic peripheral neuropathy: a meta-analysisMin-Shan Jiang, Ying Yuan, Zhao-Xiang Gu, et al.
Blood Advances|November 7, 2025
Clinical Trial Success Rate in Lymphoma: Fate of Trials and Agents from 2000 to 2019Zhiping Luo, Meng Li, Brian Primeaux, et al.
Molecules (Basel, Switzerland)|October 2, 2019
Bilobalide Suppresses Adipogenesis in 3T3-L1 Adipocytes via the AMPK Signaling PathwaySu Bu, Chun Ying Yuan, Quan Xue, et al.
Zhong Xi Yi Jie He Xue Bao = Journal of Chinese Integrative Medicine|July 13, 2005
[Effects of Anxin Granules on blood lipid and ultrastructure of aorta in rabbits with dyslipidemia]Xian-Ming Fang, Ying Yuan, Yun-Hong Wu, et al.
AJR. American Journal of Roentgenology|June 23, 2010
Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a meta-analysisYing Yuan, Xiao-Song Chen, Shi-Yuan Liu, et al.
European Journal of Radiology|April 9, 2013
Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of malignant from benign orbital massesYing Yuan, Xin-Ping Kuai, Xiao-Song Chen, et al.
Clinical Trials (London, England)|June 14, 2023
BASIC: A Bayesian adaptive synthetic-control design for phase II clinical trialsLiyun Jiang, Peter F Thall, Fangrong Yan, et al.
Pageof 183